Journal
FERTILITY AND STERILITY
Volume 116, Issue 6, Pages 1449-1454Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2021.10.025
Keywords
Recurrent implantation failure; peripheral blood mononuclear cells; platelet rich plasma; granulocyte colony stimulating factor
Categories
Ask authors/readers for more resources
Progress is being made in therapeutic options for recurrent implantation failure, with promising treatments including immune therapies like peripheral blood mononuclear cells, platelet rich plasma, and subcutaneous granulocyte-colony stimulating factor.
Despite the challenges in studying recurrent implantation failure, progress is currently being made in therapeutic options to help those who suffer from recurrent implantation failure. Three of the most promising therapeutic options for recurrent implantation failure include immune therapies such as peripheral blood mononuclear cells, platelet rich plasma and subcutaneous granulocyte-colony stimulating factor. (C) 2021 by American Society for Reproductive Medicine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
